You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

《公司業績》先聲藥業(02096.HK)中期純利22.75億人民幣 增長34.7倍

阿思達克 08-22 03:15
先聲藥業(02096.HK)公布6月止六個月中期業績,收入33.79億人民幣(下同),按年增加25.2%。錄得純利22.75億元,增長34.7倍,每股盈利87分。不派中期息。
Relevant Stocks